{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T04:58:51Z","timestamp":1692939531354},"reference-count":26,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["RRCT"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Highly Active Antiretroviral Therapy (HAART) is composed of several\ndrugs in the antiretroviral class to better treat human immunodeficiency virus type 1 (HIV-1)\npatients. The estimation of CD4+ T cell counts and HIV-1 viral load in plasma is required to\nevaluate the treatment success of a specific HAART.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methodology:<\/jats:title>\n<jats:p>The study included the effects of NRTIs (nucleoside reverse transcriptase\ninhibitors) and novel protease inhibitors (HAART) on normal control subjects and HIV-1\npositive subjects from SGPGIMS, Lucknow, with different age groups and genders. Furthermore,\nthe study was conducted by the estimation of HIV through ELISA, measurement of absolute\nCD4+ cell count, and the measurement of viral load through qRT-PCR. Furthermore, NRTIs\n(Retrovir and Epivir) were administered orally one tablet daily in the morning followed by newly\nFDA-approved protease inhibitors (fosamprenavir and darunavir) orally in the evening at the\nsame dose. Furthermore, CD4+T cell counts and HIV-1 viral load were investigated and\ncorrelated in patients with different genders and age groups.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Result:<\/jats:title>\n<jats:p>Administration of NRTIs and novel protease inhibitors (HAART) in HIV patients had a\nsignificant effect on the CD4+ cell count in various age intervals among males and females.\nThe mean comparison of viral load distribution based on gender in CD4 +ve patients in the case\ngroup exhibited a viral load higher in females compared to males, indicating a statistically\nsignificant difference between males and females (p&lt;0.05). A notable association between\nvirological and immunological parameters was observed with a reciprocal relationship between\nviral load and CD4 cell count in CD4 +ve patients, demonstrating multiple correlation\ncoefficients with an R-value of 0.853.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The administration of specific HAART (NRTIs and novel protease inhibitors) in\nHIV patients had a notable improvement in the CD4+ cell count and viral load with significant\nage and gender disparity.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1574887117666220817123002","type":"journal-article","created":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T12:00:01Z","timestamp":1660824001000},"page":"195-207","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Age and Gender Disparity on CD4+ Cell Counts to Control\nDisease Progression Using Specific HAART in HIV-1 Positive Patients: A\nCase-Control Study"],"prefix":"10.2174","volume":"17","author":[{"given":"Aakansha","family":"Singh","sequence":"first","affiliation":[{"name":"Process and Medicinal Chemistry, CSIR-Central Drug Research Institute, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoj","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of\nMicrobiology, Sanjay Gandhi Post Graduate Institude of Medical Sciences, Lucknow-226014, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashok K.","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of\nPharmacology, Pennsylvania State University, Penn State College of Medicine, Hershey, PA,-17033, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neeraj","family":"Verma","sequence":"additional","affiliation":[{"name":"Goel\nInstitute of Pharmacy and Sciences, Faizabad Road, Lucknow - 226028, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.3889\/oamjms.2019.479","volume":"7","author":"Utama S.","year":"2019","unstructured":"Utama S.; Patriawan P.; Dewi A.; Correlation of CD4\/CD8 ratio with carotid intima-media layer thickness in HIV\/AIDS patients at Sanglah General Hospital, Bali, Indonesia. Open Access Maced J Med Sci 2019,7(11),1803-1807","journal-title":"Open Access Maced J Med Sci"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/0167-5699(96)10049-9","volume":"17","author":"Amadori A.","year":"1996","unstructured":"Amadori A.; Zamarchi R.; Chieco-Bianchi L.; CD4: CD8 ratio and HIV infection: The \"tap-and-drain\u2019 hypothesis. Immunol Today 1996,17(9),414-417","journal-title":"Immunol Today"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3851\/IMP3155","volume":"22","author":"Petoumenos K.","year":"2017","unstructured":"Petoumenos K.; Choi J.Y.; Hoy J.; CD4:CD8 ratio comparison between cohorts of HIV-positive Asians and Caucasians upon commencement of antiretroviral therapy. Antivir Ther 2017,22(8),659-668","journal-title":"Antivir Ther"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.4049\/jimmunol.1002000","volume":"186","author":"Catalfamo M.","year":"2011","unstructured":"Catalfamo M.; Wilhelm C.; Tcheung L.; CD4 and CD8 T cell immune activation during chronic HIV infection: Roles of homeostasis, HIV, type I IFN, and IL-7. J Immunol 2011,186(4),2106-2116","journal-title":"J Immunol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1016\/S2352-3018(15)00006-5","volume":"2","author":"Mussini C.","year":"2015","unstructured":"Mussini C.; Lorenzini P.; Cozzi-Lepri A.; CD4\/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study. Lancet HIV 2015,2(3),e98-e106","journal-title":"Lancet HIV"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"e3108","DOI":"10.1097\/MD.0000000000003108","volume":"95","author":"Masi\u00e1 M.","year":"2016","unstructured":"Masi\u00e1 M.; Padilla S.; Barber X.; Comparative impact of suppressive antiretroviral regimens on the CD4\/CD8 T-cell ratio: A cohort study. Medicine (Baltimore) 2016,95(11),e3108","journal-title":"Medicine (Baltimore)"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"e97011","DOI":"10.1371\/journal.pone.0097011","volume":"9","author":"Tinago W.","year":"2014","unstructured":"Tinago W.; Coghlan E.; Macken A.; Clinical, immunological and treatment-related factors associated with normalised CD4+\/CD8+ T-cell ratio: Effect of na\u00efve and memory T-cell subsets. PLoS One 2014,9(5),e97011","journal-title":"PLoS One"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1086\/504718","volume":"194","author":"Goicoechea M.","year":"2006","unstructured":"Goicoechea M.; Smith D.M.; Liu L.; Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: Association of immune activation, T cell maturation markers, and cellular HIV-1 DNA. J Infect Dis 2006,194(1),29-37","journal-title":"J Infect Dis"},{"key":"ref=9","first-page":"31S","volume":"33","author":"Gibert C.L.","year":"2016","unstructured":"Gibert C.L.; Treatment guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents: An update. Fed Pract 2016,33(3),31S-36S","journal-title":"Fed Pract"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1506816","volume":"373","author":"Lundgren J.D.","year":"2015","unstructured":"Lundgren J.D.; Babiker A.G.; Gordin F.; Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med 2015,373(9),795-807","journal-title":"N Engl J Med"},{"key":"ref=11","year":"2010","unstructured":"WHO Technical Brief Viral Load DRAFT _June 2010 docx WHO World Health OrganizationAvailable from: 2010","journal-title":"WHO Technical Brief Viral Load DRAFT _June 2010 docx WHO"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1177\/0956462419834129","volume":"30","author":"Monsalvo M.","year":"2019","unstructured":"Monsalvo M.; Vallejo A.; Fontecha M.; Vivancos M.J.; Vizcarra P.; Casado J.L.; CD4\/CD8 ratio improvement in HIV-1-infected patients receiving dual antiretroviral treatment. Int J STD AIDS 2019,30(7),656-662","journal-title":"Int J STD AIDS"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1001\/jama.2018.21167","volume":"321","author":"Eisinger R.W.","year":"2019","unstructured":"Eisinger R.W.; Dieffenbach C.W.; Fauci A.S.; HIV viral load and transmissibility of HIV infection: Undetectable equals untransmittable. JAMA 2019,321(5),451-452","journal-title":"JAMA"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"e1001095","DOI":"10.1371\/journal.pmed.1001095","volume":"8","author":"Koenig S.P.","year":"2011","unstructured":"Koenig S.P.; Bang H.; Severe P.; Cost-effectiveness of early versus standard antiretroviral therapy in HIV-infected adults in Haiti. PLoS Med 2011,8(9),e1001095","journal-title":"PLoS Med"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3904\/kjim.2015.30.5.705","volume":"30","author":"Kim K.H.","year":"2015","unstructured":"Kim K.H.; Yi J.; Lee S.H.; The CD4 slope can be a predictor of immunologic recovery in advanced HIV patients: A case-control study. Korean J Intern Med (Korean Assoc Intern Med) 2015,30(5),705-713","journal-title":"Korean J Intern Med (Korean Assoc Intern Med)"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1056\/NEJMoa062360","volume":"355","author":"El-Sadr W.M.","year":"2006","unstructured":"El-Sadr W.M.; Lundgren J.; Neaton J.D.; CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 2006,355(22),2283-2296","journal-title":"N Engl J Med"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.cca.2016.02.022","volume":"456","author":"Bystryak S.","year":"2016","unstructured":"Bystryak S.; Acharya C.; Detection of HIV-1 p24 antigen in patients with varying degrees of viremia using an ELISA with a photochemical signal amplification system. Clin Chim Acta 2016,456,128-136","journal-title":"Clin Chim Acta"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3390\/pathogens9121047","volume":"9","author":"Macchi B.","year":"2020","unstructured":"Macchi B.; Frezza C.; Marino-Merlo F.; Appraisal of a simple and effective RT-qPCR assay for evaluating the reverse transcriptase activity in blood samples from HIV-1 patients. Pathogens 2020,9(12),1047","journal-title":"Pathogens"},{"key":"ref=19","first-page":"1183","volume":"6","author":"Kumar M.","year":"2019","unstructured":"Kumar M.; Kumar R.; Mahdi A.A.; CD4 count pattern and demographic distribution in HIV positive patients in northern part of India. J Fam Med 2019,6(6),1183","journal-title":"J Fam Med"},{"key":"ref=20","first-page":"22","volume":"1","author":"Yar\u2019zever I.S.","year":"2013","unstructured":"Yar\u2019zever I.S.; Abubakar U.; Toriola A.L.; Effects of 12 weeks cycle exercise programme on CD4 count and viral load in HIV sero-positive patients in Kano, Nigeria. Global Sci Res J 2013,1(1),22-28","journal-title":"Global Sci Res J"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1056\/NEJMoa0903175","volume":"361","author":"Abrams D.","year":"2009","unstructured":"Abrams D.; L\u00e9vy Y.; Losso M.H.; Interleukin-2 therapy in patients with HIV infection. N Engl J Med 2009,361(16),1548-1559","journal-title":"N Engl J Med"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1056\/NEJM199610313351803","volume":"335","author":"Kovacs J.A.","year":"1996","unstructured":"Kovacs J.A.; Vogel S.; Albert J.M.; Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. N Engl J Med 1996,335(18),1350-1356","journal-title":"N Engl J Med"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2165\/00007256-199928060-00002","volume":"28","author":"Stringer W.W.","year":"1999","unstructured":"Stringer W.W.; HIV and aerobic exercise. Current recommendations. Sports Med 1999,28(6),389-395","journal-title":"Sports Med"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1177\/00333549071220S106","volume":"122","author":"Gallagher K.M.","year":"2007","unstructured":"Gallagher K.M.; Sullivan P.S.; Lansky A.; Onorato I.M.; Behavioral surveillance among people at risk for HIV infection in the U.S.: The national HIV behavioral surveillance system. Public Health Rep 2007,122(1),32-38","journal-title":"Public Health Rep"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"e97596","DOI":"10.1371\/journal.pone.0097596","volume":"9","author":"Lansky A.","year":"2014","unstructured":"Lansky A.; Finlayson T.; Johnson C.; Estimating the number of persons who inject drugs in the United States by meta-analysis to calculate national rates of HIV and hepatitis C virus infections. PLoS One 2014,9(5),e97596","journal-title":"PLoS One"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1089\/apc.1999.13.717","volume":"13","author":"Halperin D.T.","year":"1999","unstructured":"Halperin D.T.; Heterosexual anal intercourse: Prevalence, cultural factors, and HIV infection and other health risks, Part I. AIDS Patient Care STDS 1999,13(12),717-730","journal-title":"AIDS Patient Care STDS"}],"container-title":["Reviews on Recent Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1574887117666220817123002","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/207595\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1574887117666220817123002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T15:53:56Z","timestamp":1692892436000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/207595\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574887117666220817123002","relation":{},"ISSN":["1574-8871"],"issn-type":[{"value":"1574-8871","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-02-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}